PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

NRC Health

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from NRC Health's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 97% of Healthcare companies in United States.
  • Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.

Where $100 of sales goes

$84Operating costs$3.5Interest$8.4Net profit$8.0Paid as dividends

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

$147

Over the last 3 years, every $100 of reported profit came with $147 of operating cash.

Lower than 52% of Healthcare companies in United States.

Self-Funding Ratio

2.4×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.4 times.

Higher than 76% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

0/3 · 0/3

Sales and profit both fell in each of the last 3 years.

Less steady than 96% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 9%

Sales fell 9% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-9% / +3%

In 3 years sales changed by -9% while total assets changed by +3%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

6.6×

Debt due within a year is covered 6.6 times by its yearly operating cash.

Higher than 82% of Healthcare companies in United States.

Cash Cushion Ratio

−16%

Debt, after subtracting cash, equals 16% of its market value (net debt).

Lower than 82% of Healthcare companies in United States.

Tangible Assets Ratio

49%

Of every $100 the company owns, $49 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 81% of Healthcare companies in United States.

Tangible Net Worth Ratio

Negative

Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.

Less tangible than 97% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

−8%

Share count fell 8% in 3 years (buybacks), so each share's slice of the company became larger. Dividends paid equalled 87% of profit over the same period.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (14)

NRC Health owes $0.95 for every $1 it owns. Net profit fell 53% in the year to Dec 2025, and shrank 29% a year on average over 3 years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

89.1

Investors pay $89.1 for every $1 of NRC Health's yearly profit, higher than 89% of Healthcare companies in United States.

P/B ratio

72.21

The share price is 72.21 times NRC Health's book value per share, higher than 98% of Healthcare companies in United States.

Market cap

$473 M

The total market value of all of NRC Health's shares at today's price (share price × number of shares), larger than 54% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$7 M

What NRC Health would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$0.30

Net worth divided by the number of shares. The share price of $21.38 is 72.2 times this, which is the P/B above.

Return on equity (ROE)

42.0%

NRC Health earned 42.0% on its shareholders' money over the last year, higher than 96% of Healthcare companies in United States.

Owes vs Owns

0.95×

NRC Health owes $0.95 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.

Dividend yield

3.15%

NRC Health pays 3.15% of its share price as dividends a year, higher than 92% of dividend-paying Healthcare companies in United States.

Revenue growth

-4%

Revenue fell 4% in the year to Dec 2025, and shrank 3% a year on average over 3 years.

Profit growth

-53%

Net profit fell 53% in the year to Dec 2025, and shrank 29% a year on average over 3 years.

Profit margin

8.4%

NRC Health keeps $8 of every $100 of revenue as net profit.

Cash quality

2.3×

Cash from NRC Health's business was 2.3× its reported profit in the year to Dec 2025 — its profit turned into cash.

Interest cover

4.7×

NRC Health's operating profit covered its interest costs 4.7 times in the year to Dec 2025.

Cash vs debt

Net debt

NRC Health had $75 M more debt than cash (net debt) at Dec 2025.

Questions

What is NRC Health's P/E ratio?

Investors pay $89.1 for every $1 of NRC Health's yearly profit, higher than 89% of Healthcare companies in United States.

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For NRC Health: $473 M ÷ $7 M (30 Jun 2026) = 72.2.

What is NRC Health's return on equity?

NRC Health earned 42.0% on its shareholders' money over the last year, higher than 96% of Healthcare companies in United States.

How much does NRC Health owe compared with what it owns?

NRC Health owes $0.95 for every $1 it owns (high), higher than 85% of Healthcare companies in United States.

Does NRC Health pay a dividend?

Yes. NRC Health pays 3.15% of its share price as dividends a year, higher than 92% of dividend-paying Healthcare companies in United States.

Is NRC Health's revenue growing?

Revenue fell 4% in the year to Dec 2025, and shrank 3% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.